Login / Signup

Edaravone: A Novel Possible Drug for Cancer Treatment?

Elisa DurantiNicoletta CordaniChiara Villa
Published in: International journal of molecular sciences (2024)
Despite significant advancements in understanding the causes and progression of tumors, cancer remains one of the leading causes of death worldwide. In light of advances in cancer therapy, there has been a growing interest in drug repurposing, which involves exploring new uses for medications that are already approved for clinical use. One such medication is edaravone, which is currently used to manage patients with cerebral infarction and amyotrophic lateral sclerosis. Due to its antioxidant and anti-inflammatory properties, edaravone has also been investigated for its potential activities in treating cancer, notably as an anti-proliferative and cytoprotective drug against side effects induced by traditional cancer therapies. This comprehensive review aims to provide updates on the various applications of edaravone in cancer therapy. It explores its potential as a standalone antitumor drug, either used alone or in combination with other medications, as well as its role as an adjuvant to mitigate the side effects of conventional anticancer treatments.
Keyphrases
  • cancer therapy
  • papillary thyroid
  • anti inflammatory
  • amyotrophic lateral sclerosis
  • squamous cell
  • adverse drug
  • drug delivery
  • healthcare
  • early stage
  • oxidative stress
  • atomic force microscopy